FREE Case Evaluation: 1-888-887-3117
The relaxer cancer lawsuit is a major product liability case involving thousands of women who developed cancer after long-term use of chemical hair straighteners.
Current Status of Relaxer Cancer Lawsuits:
This crisis gained national attention after a 2022 National Institutes of Health study found that women who used chemical hair relaxers more than four times per year were more than twice as likely to develop uterine cancer. The study also highlighted a disproportionate impact on Black women, who made up 60% of the participants using these products.
As Sheila Bush, a cosmetologist diagnosed with uterine cancer, told Reuters: "I was lounging in the recliner at my St. Louis-area home last winter when an advertisement from a law firm flashed up on my television screen, urging viewers to call a toll-free number if they or a loved one had used hair relaxers and been diagnosed with uterine cancer."
I'm Tim Burd, founder of Justice Hero. My work in mass tort litigation has shown me how the relaxer cancer lawsuit unites thousands of women seeking accountability from manufacturers for allegedly failing to warn them of these risks. I've seen the need for clear information in complex cases like this.
Hair relaxers use a chemical cocktail to permanently break down the bonds in hair, creating a straighter look but also exposing users to a mix of concerning chemicals.
The primary concern involves Endocrine-Disrupting Chemicals (EDCs), which interfere with the body's hormone system. EDCs can mimic or block natural hormones like estrogen, disrupting hormonal balance and potentially leading to cancer.
These relaxers often contain harmful chemicals, including:
Exposure occurs through both scalp absorption (especially with cuts or irritation) and inhalation of fumes during heating, making the health risks in the relaxer cancer lawsuit particularly serious. The growing body of research from institutions like the National Institutes of Health and the Sister Study Researchers has been instrumental in documenting these risks.
The relaxer cancer lawsuit focuses on several cancers and reproductive health issues linked to chemical hair straighteners.
Uterine cancer is at the heart of most claims. Studies show a significantly increased risk for frequent relaxer users. This includes the more common endometrial cancer and the more aggressive uterine sarcoma. Black women face higher rates of aggressive uterine cancer subtypes and higher mortality rates. For more information, the National Institutes of Health offers detailed resources.
Endometrial cancer represents the vast majority of uterine cancer cases in the litigation. A 2022 study found that 94.7% of reported uterine cancer cases linked to relaxers were specifically endometrial cancer.
Ovarian cancer research is also concerning. A 2021 study in Carcinogenesis linked frequent relaxer use to a doubled risk of ovarian cancer, which is often detected late due to a lack of early symptoms.
Breast cancer is another concern. Research in the International Journal of Cancer found up to a 31% increased breast cancer risk for frequent users, with a disproportionate risk for Black women.
Uterine fibroids, non-cancerous growths linked to relaxer use, are also part of the lawsuit, as they can necessitate major surgeries like hysterectomy.
The National Institute of Environmental Health Sciences (NIEHS) "Sister Study" provides the cornerstone research for the relaxer cancer lawsuit. It is one of the most comprehensive investigations into environmental and genetic cancer risk factors.
The study followed over 33,000 women aged 35-74 for more than a decade, collecting detailed health and lifestyle data.
Published in the Journal of the National Cancer Institute in October 2022, its key finding was that women using chemical straighteners more than four times a year were more than twice as likely to develop uterine cancer than non-users.
By age 70, the study projected a uterine cancer rate of 4.05% for frequent users, compared to 1.64% for non-users—a significant increase in risk.
Crucially, the study revealed that approximately 60% of participants who used chemical straighteners identified as Black women, highlighting how these products disproportionately affect this community. These findings provide the scientific foundation for thousands of claims in the relaxer cancer lawsuit.
The massive wave of lawsuits following cancer diagnoses linked to hair straighteners required a specialized legal approach. Understanding the management of the relaxer cancer lawsuit is key to navigating your legal options.
The federal court system uses Multidistrict Litigation (MDL) to handle such cases. An MDL consolidates thousands of similar lawsuits from across the country before a single judge for more efficient pretrial proceedings. Unlike a class action, each person in an MDL retains their individual case. The process allows for bellwether trials—test cases that help both sides gauge how juries might react to the evidence.
The hair relaxer cancer lawsuit was consolidated into MDL 3060 on February 6, 2023. It is formally named "In Re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation" and is overseen by Judge Mary M. Rowland in the Northern District of Illinois.
The scope of the crisis is clear from the numbers. The MDL began with thousands of cases and grew to 10,858 pending lawsuits by September 2025, with more women filing each month.
If you're wondering whether you might have a case, learning about your options is the first step. You can find more detailed information about working with legal professionals on our Hair Straightener Lawsuit Lawyer page.
The relaxer cancer lawsuit targets some of the biggest names in the beauty industry.
The legal battle centers on what manufacturers knew and when, and what they failed to do to protect consumers.
Plaintiffs argue that manufacturers are liable for:
The lawsuits also have a civil rights dimension, arguing that companies profited by exploiting societal pressures on Black women to conform to Eurocentric beauty standards.
Defendants argue there is no definitive proof their products cause cancer, claiming their products are safe and comply with FDA regulations. They also attempt to shift blame to other factors like genetics or lifestyle choices.
In response to the lawsuits and scientific evidence, the FDA proposed a ban on formaldehyde and formaldehyde-releasing chemicals in hair straighteners in 2023.
This proposed ban represents a significant shift in how the government views cosmetic safety. For decades, the beauty industry has operated with relatively light oversight.
However, the ban's implementation has faced delays, a point of frustration for public health advocates, as NPR reported. These delays mean women may continue to use potentially dangerous products while regulators debate.
When enacted, the ban will force companies to reformulate their products. This regulatory action adds weight to the relaxer cancer lawsuit, as it serves as a government acknowledgment of the risks involved.
If you were diagnosed with cancer after using chemical hair relaxers, understanding your legal options is the first step toward justice. The process can seem daunting, but key information can help.
Time is a critical factor. Every state has a statute of limitations, a deadline for filing a relaxer cancer lawsuit. In many cases, a "findy rule" applies, meaning the clock starts when you finded (or should have finded) the link between your cancer and hair relaxer use. For many, this was after the 2022 NIH study. Consulting an attorney promptly is crucial to determine your specific deadline.
Building a strong case requires evidence, including your medical records and proof of hair relaxer use. This can come from receipts, salon records, photos, or social media posts. Experienced attorneys can help you piece together this history.
For detailed information about what financial recovery might look like in these cases, you can learn more about Hair Relaxer Settlement and Payouts.
To qualify for a relaxer cancer lawsuit, your case will be evaluated on three key factors: your diagnosis, your history of relaxer use, and the timing.
A successful relaxer cancer lawsuit can help recover damages for both financial losses and the profound impact on your quality of life.
Compensation amounts vary based on individual factors like age, illness severity, and medical costs. A successful lawsuit can provide financial security to help you focus on your health.
We understand that navigating a complex legal issue like the relaxer cancer lawsuit can bring up many questions. Here, we address some of the most common inquiries we hear.
It is too early to state definitive settlement amounts, as the relaxer cancer lawsuit is in its early stages and no settlements have been reached as of October 1, 2024. Bellwether trials, which will help establish case values, are not expected until 2027.
The value of any lawsuit depends on individual factors:
Legal experts project that strong uterine cancer cases could settle for between $150,000 and $750,000, with potential for higher amounts depending on bellwether trial outcomes. Cases involving uterine fibroids requiring a hysterectomy may also result in significant compensation.
The statute of limitations, or the legal deadline to file, is the crucial factor. It varies by state, and missing it can bar you from taking legal action.
However, the "findy rule" often applies, meaning the deadline may not start until you knew or should have known that your health issue was linked to hair relaxer use. Since the key NIH study was published in late 2022, many people are still within their filing window.
It is critical to consult with an attorney immediately to determine your specific deadline.
An MDL is a legal procedure used to manage complex cases involving many plaintiffs with similar claims against the same defendants. Here’s how it works:
The relaxer cancer lawsuit is a pivotal moment for thousands of women facing devastating health issues after decades of using trusted beauty products. For many, this has led to life-altering cancer diagnoses, invasive treatments, and lost fertility.
The scientific evidence linking chemical hair relaxers to cancer continues to grow, with the landmark NIH Sister Study providing a strong foundation for the over 9,000 cases now consolidated in federal court. This is a widespread crisis that demands accountability.
For Black women in particular, these products were often tied to societal and professional pressures. The allegation that brands knew of the risks while marketing to these communities adds a layer of injustice to an already painful situation.
If you used chemical hair relaxers and later developed uterine cancer, endometrial cancer, ovarian cancer, or severe uterine fibroids requiring surgery, you may have legal options worth exploring. At Justice Hero, we simplify complex legal topics to empower you to make informed decisions. The legal process can be overwhelming, but you don't have to steer it alone.
State-specific statutes of limitation mean time is critical. Waiting could jeopardize your right to seek justice. We are here to help you understand every step of the process.
Take the time to learn more about your options in a Hair Relaxer Lawsuit and find how you can move forward with confidence. Your health, your story, and your fight for justice matter—and the right legal guidance can make all the difference in achieving the accountability and compensation you deserve.
Connect with us today through our Hair Relaxer Contact Form to take the first step toward understanding your legal rights and options.
